CClinicalTrials.gg
CompletedNCT06596395CAF+BJUpdated Sep 19, 2024

Effect of Acute Caffeine and Beetroot Juice Intake on Strength, Power, and Muscular Endurance

An interventional study of Acute caffeine and beetroot juice and Acute caffeine in Dietary Supplements, Caffeine and Nitrates, sponsored by University of Alcala. Completed at 1 site in Spain. Open to male participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-09-19.

Sponsored by University of Alcala · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 1 year after the study started (first participant enrolled Sep 2023, registered Sep 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
14
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
Male
01

Study summary

Introduction: Several studies have evaluated and confirmed the ergogenic effect of acute caffeine and beetroot juice intake on sports performance. However, there are few studies focused on the production of strength, power, and muscle endurance, particularly when both supplements are ingested together.

Objectives: Evaluate the acute effect of combined and isolated intake of caffeine and beetroot juice on the production of strength, power, and muscle endurance in young adults, analyzing the effect of circadian rhythms (morning vs. afternoon) on the exercise performed (bench press vs. squat).

Methods: A total of 12 healthy and physically active participants will be recruited for the study. Through a double-blind, crossover, randomized, and controlled design, participants will ingest: a) Caffeine (3 mg/kg body mass); b) Beetroot juice (70 ml, 6.5 mmol of nitrates); c) Caffeine + Beetroot juice; d) Placebo (maltodextrin, 3 mg/kg). The supplements will be ingested 120 minutes (beetroot juice or placebo) and 60 minutes before (caffeine or placebo), the latter dissolved in 200 ml of water. After the ingestion period, strength, power, and muscle endurance will be analyzed with 1RM tests, strength and power tests at 25%, 50%, 75%, and 90% 1RM, and muscle endurance tests at 65% 1RM, in all cases for squat and bench press exercises. Additionally, dynamometry (manual and the isometric mid-thigh pull test) and vertical jump (squat jump and countermovement jump) will be analyzed. The four experimental conditions will be conducted in the morning (8:00 am to 10:00 am) and in the afternoon (4:30 pm to 6:30 pm).

02

Conditions studied

  • Dietary Supplements
  • Caffeine
  • Nitrates
  • Sports Performance
  • Resistance Exercise
03

In context

Lead sponsor

University of Alcala is the lead sponsor of 123 studies on the registry; 36 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Inclusion criteria

  • Age between ≥ 18 and ≤ 35 years.
  • Body Mass Index (BMI) \< 25 kg/m².
  • Resistance-trained individuals (\> 2 years of structured trained).
  • Healthy men and women without neurological, cardiometabolic, immunological, or physical conditions that prevent them from exercising.
  • Participants must be able to perform the tests described in the following section.

Exclusion criteria

Exclusion Criteria:

  • History of neuromuscular diseases, heart diseases, or diseases that may affect liver or muscle metabolism.
  • Use of drugs, other stimulants or sport supplements that interfere with the intake of the study\'s dietary supplements.
  • Sedentary habits (\< 150 min/week of moderate exercise).
  • Having undergone prolonged periods of forced physical inactivity during the 6 months prior to the study.
  • Performing strenuous exercise during the 48 hours prior to the tests.
  • Failure to replicate the same food intake on the two days of the experiments.
  • Consuming caffeine or any other stimulant after 6 pm the day before the training or tests, to avoid headaches, discomfort, or lethargy among regular caffeine consumers.
  • Consuming foods rich in NO3- (e.g., beetroot, spinach, or celery) during the 48 hours prior to each experimental condition.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
14 participants (actual)

Study arms

  • Experimental
    Caffeine + Beetroot Juice

    70 mL of concentrated NO3--rich (BJ, 6.5 mmol NO3-) + 3 mg/kg of caffeine

    Dietary Supplement: Acute caffeine and beetroot juice

  • Experimental
    Beetroot Juice

    70 mL of concentrated NO3--rich (BJ, 6.5 mmol NO3-) + 3 mg/kg of placebo (maltodextrin)

    Dietary Supplement: Acute beetroot juice

  • Experimental
    Caffeine

    70 mL of NO3--depleted (BJ, 0.04 mmol NO3-) + 3 mg/kg of caffeine

    Dietary Supplement: Acute caffeine

  • Placebo comparator
    Placebo

    70 mL of NO3--depleted (BJ, 0.04 mmol NO3-) + 3 mg/kg of placebo (maltodextrin)

    Dietary Supplement: Placebo

Interventions

  • Dietary supplementAcute caffeine and beetroot juice

    Combined effect of beetroot juice and caffeine intake on muscular strength, power and endurance performance

  • Dietary supplementAcute caffeine

    single effect of caffeine intake on muscular strength, power and endurance performance

  • Dietary supplementAcute beetroot juice

    single effect of beetroot juice intake on muscular strength, power and endurance performance

  • Dietary supplementPlacebo

    single effect of placebo on muscular strength, power and endurance performance

06

What researchers measure

Primary outcomes

  1. Mean and peak velocity and time to reach peak velocity at different %1RM

    Measuring bar velocity desplacement during bench press and back squat exercises.

    Time frame: On each trial, after dietary supplement intake, during 2 weeks

  2. Mean and peak power output and time to reach peak power output at different %1RM

    Measuring power output generated during bench press and back squat exercises.

    Time frame: On each trial, after dietary supplement intake, during 2 weeks

  3. Number of repetitions performed at 65%1RM until task failure

    Additionally to mean and peak velocity, mean and peak power output, time to reach peak velocity and peak power

    Time frame: On each trial, after dietary supplement intake, during 2 weeks

Secondary outcomes

  1. Mood state (tension, depression, anger, vigor, fatigue and confusion)

    Participants graded a set of 29 items related to the mood on a Likert scale from 0 (not at all) to 4 (extremely) in reply to the question \"How do you feel at this moment?\" to assess six scales: tension, depression, anger, vigor, fatigue and confusion.

    Time frame: On each trial, after dietary supplement intake, during 2 weeks

  2. Adverse effects

    perception of power, endurance, energy and exertion, as well as heart, muscular and gastrointestinal discomfort.

    Time frame: On each trial, after dietary supplement intake, during 2 weeks

  3. handgrip and isometric mid-thigh pull tests

    N generated

    Time frame: On each trial, after dietary supplement intake, during 2 weeks

  4. Vertical Jump (cm and power)

    Time frame: On each trial, after dietary supplement intake, during 2 weeks

07

Study locations

1 site
  • Facultad de Medicina y Ciencias de la Salud. Universidad de Alcalá
    Alcalá de Henares, Madrid 28805, Spain
08

References and documents

Individual participant data

Plan to share: Yes

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06596395
Lead sponsor
University of Alcala
Responsible party
Alberto Pérez-López (Principal Investigator, University of Alcala) — Principal investigator
First posted
Sep 19, 2024
Start date
Sep 1, 2023
Primary completion
Jan 30, 2024
Completion
May 1, 2024
Last update
Sep 19, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion